These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36835416)

  • 1. Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C
    Ejima R; Suzuki H; Tanaka T; Asano T; Kaneko MK; Kato Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Anti-CD44 Variant 3 Monoclonal Antibody C
    Suzuki H; Kitamura K; Goto N; Ishikawa K; Ouchida T; Tanaka T; Kaneko MK; Kato Y
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Anti-CD44 Variant 9 Monoclonal Antibody C
    Tawara M; Suzuki H; Goto N; Tanaka T; Kaneko MK; Kato Y
    Curr Issues Mol Biol; 2023 Apr; 45(4):3658-3673. PubMed ID: 37185762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Novel Anti-CD44 Monoclonal Antibody for Multiple Applications against Esophageal Squamous Cell Carcinomas.
    Goto N; Suzuki H; Tanaka T; Asano T; Kaneko MK; Kato Y
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C
    Suzuki H; Tanaka T; Goto N; Kaneko MK; Kato Y
    Curr Issues Mol Biol; 2023 Feb; 45(3):1875-1888. PubMed ID: 36975491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C
    Kudo Y; Suzuki H; Tanaka T; Kaneko MK; Kato Y
    Antibodies (Basel); 2023 Apr; 12(2):. PubMed ID: 37218897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C
    Suzuki H; Ozawa K; Tanaka T; Kaneko MK; Kato Y
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C
    Ishikawa K; Suzuki H; Kaneko MK; Kato Y
    Curr Issues Mol Biol; 2023 Jun; 45(7):5248-5262. PubMed ID: 37504249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas.
    Ishikawa K; Suzuki H; Ohishi T; Li G; Tanaka T; Kawada M; Ohkoshi A; Kaneko MK; Katori Y; Kato Y
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C
    Suzuki H; Goto N; Tanaka T; Ouchida T; Kaneko MK; Kato Y
    Antibodies (Basel); 2023 Jul; 12(3):. PubMed ID: 37489367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C
    Suzuki H; Tawara M; Hirayama A; Goto N; Tanaka T; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Jun; 43(3):85-89. PubMed ID: 38507669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C
    Asano T; Kaneko MK; Takei J; Tateyama N; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):156-161. PubMed ID: 34283655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C
    Takei J; Asano T; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):219-226. PubMed ID: 34678095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C
    Yamada S; Itai S; Nakamura T; Yanaka M; Kaneko MK; Kato Y
    Biochem Biophys Rep; 2018 Jul; 14():64-68. PubMed ID: 29872736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of a peptide-based monoclonal antibody against CD44 variant 6.
    Zarei S; Bayat AA; Hadavi R; Mahmoudi AR; Tavangar B; Vojgani Y; Jeddi-Tehrani M; Amirghofran Z
    Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):36-43. PubMed ID: 25723282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44v6 engages in colorectal cancer progression.
    Ma L; Dong L; Chang P
    Cell Death Dis; 2019 Jan; 10(1):30. PubMed ID: 30631039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
    Takei J; Kaneko MK; Ohishi T; Hosono H; Nakamura T; Yanaka M; Sano M; Asano T; Sayama Y; Kawada M; Harada H; Kato Y
    Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications.
    Li G; Suzuki H; Asano T; Tanaka T; Suzuki H; Kaneko MK; Kato Y
    Antibodies (Basel); 2022 Jun; 11(2):. PubMed ID: 35735360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a sandwich enzyme-linked immunosorbent assay for the detection of CD44v3 using exon v3- and v6-specific monoclonal antibody pairs.
    Jeoung MH; Kim TK; Shim H; Lee S
    J Immunol Methods; 2016 Sep; 436():22-8. PubMed ID: 27288967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.